Theorem Think Tank Debuts in Boston March 7

KING OF PRUSSIA, Pa. -- (BUSINESS WIRE) -- The first Theorem Think Tank on drug development will be held in Boston from 3-7 p.m., March 7. Led by noted leaders in their respective fields, the six sessions offer insight into key aspects of the drug and medical device development process for groups and individuals seeking a better understanding. There is no cost to attend.

“This is a fabulous opportunity for people working in pharmaceutical companies, academia or research organizations to gain a broader perspective on the whole pharmaceutical and medical device development continuum,” said Dr. John Potthoff, Theorem Clinical Research president and CEO.

Sessions are divided into two tracks, enabling participants to choose among the topics.

3 p.m.

• Think Regulatory — "Strategic Regulatory Insight to Bring Your Device or Drug to Market in Record Time,” with Brian Bollwage, JD, Theorem vice president of global regulatory affairs
• Think Patients — “Electronic Patient Discovery With PatientLocate^SM," with Dan Carnese, KDH Systems CEO

4 p.m.

• Think Therapeutics — “Patient Recruitment for Oncology Studies: Improving Your Probability for Success," with Connie Wierman, Theorem vice president, biopharmaceutical development
• Think CDISC — "BIMO (Summary Level Clinical Site Data for CDER's Inspection Planning) – What is it all about?" with Nate Freimark, Theorem senior director of the biometrics operations standards group

5 p.m.

• Think Strategy — "Adaptive Clinical Trial Designs – Operational Considerations," with Mark Penniston, Theorem senior vice president and general manager, clinical analytics
• Think Global — "Unraveling the Mystery of Delivery of Medical Device Trials in the Asia-Pacific," with D. Lee Spurgin, Jr., PhD, Theorem senior vice president and general manager, medical device and diagnostic development, and Nitin Jain, Theorem vice president and general manager for the Asia-Pacific region

The Theorem Think Tank will be held at the Boston Marriott Cambridge, 50 Broadway, Cambridge, Mass. Registration is free, but must be completed in advance.

“If you’re involved in the drug development industry, this is a rare opportunity to gain important insights from some of the real leaders in contract research,” Potthoff said. “Take us up on this chance to ask the questions you’ve always wanted to ask, talk one-on-one with leading experts and get valuable advice on your own development programs.”

About Theorem Clinical Research

Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's leading pharmaceutical, biotech and medical device companies. A leader in medical device and drug-device combination trials in addition to a notable capability in pharmaceuticals and biologics, Theorem has deep expertise in a broad range of therapeutic areas and in all phases of development. Some of the industry's top scientists and most advanced clinical analytics capabilities help ensure smooth-running, successful trials. For a full-service, right-size global research partner, don't think twice. THINK THEOREM.